 This research suggests that combining the delivery of a functional small INA and an anti-cancer drug using engineered exosomes can be used to reverse drug resistance in colorectal cancer cells. This strategy may provide a promising approach to improve the efficacy of cancer treatments. This article was authored by Gafeng Liang, Yang Liangzhu, Duluthuna Sejafa Ali, and others.